the pulmonary-proteoliposome as a new therapeutic approach for coronaviruses. ¬© 2020, ¬© 2020 The Author(s). Published with license by Taylor & Francis Group, LLC.We are proposing√Ç the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave off the infection.